3 July, 2021 by The TZ Newswire Staff Comments Off on Can Emergent BioSolutions Recover From Its Recent Blunders?
Can Emergent BioSolutions Recover From Its Recent Blunders?
They say that any publicity is good publicity. Emergent BioSolutions (NYSE: EBS) might disagree after its highly publicized COVID-19 vaccine manufacturing problems. In this Motley Fool Live video recorded on June 23, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer’s question about whether or not Emergent BioSolutions can recover from its recent blunders.
3 July, 2021 by The TZ Newswire Staff Comments Off on Better Buy: Boeing vs. Airbus
Better Buy: Boeing vs. Airbus
If you are thinking of buying stock in airplane manufacturers like Airbus (OTC: EADSY) or Boeing (NYSE: BA) at the moment, you probably assume that commercial air flights will get back to 2019 levels around the 2023 timeframe. That’s how many leading industry figures see matters developing.
Given that scenario, it’s likely that the demand for new airplanes will pick up, leading to higher production rates — and ultimately higher margins and profits.
3 July, 2021 by The TZ Newswire Staff Comments Off on With Prices Going Up, Consumers Will Flock to This Healthcare Tech Specialist
With Prices Going Up, Consumers Will Flock to This Healthcare Tech Specialist
In times of inflation, oftentimes employees’ wages don’t rise as fast as prices. This presents an opportunity for companies that are able to provide consumers lower costs on the things they need. GoodRx (NASDAQ: GDRX) is one of those companies. On a Motley Fool Live episode recorded on June 17, Motley Fool contributor Brian Feroldi explains why this prescription coupon service is set to thrive during inflation.
3 July, 2021 by The TZ Newswire Staff Comments Off on France Probes Fashion Retailers For Concealing “Crimes Against Humanity” In China
France Probes Fashion Retailers For Concealing “Crimes Against Humanity” In China
France Probes Fashion Retailers For Concealing “Crimes Against Humanity” In China
The government of France has opened an investigation into several fashion giants suspected of profiting off of Muslim Uyghur labor in China’s Xinjiang region, including specific efforts of concealing “crimes against humanity.”
3 July, 2021 by The TZ Newswire Staff Comments Off on Got $5,000? 3 Top Dividend Stocks to Buy Right Now
Got $5,000? 3 Top Dividend Stocks to Buy Right Now
With stocks trading in the neighborhood of record highs, some growth-focused names have been putting up eye-catching performances. However, investors can also strengthen their portfolios by adding sturdy, lower-risk companies that regularly return value to shareholders through dividends.
3 July, 2021 by The TZ Newswire Staff Comments Off on ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Robust Objective Response in Patients with Gastric or Gastroesophageal Junction Cancer
ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Robust Objective Response in Patients with Gastric or Gastroesophageal Junction Cancer
— ORR of 72% Observed in Patients with >2L HER2 Positive Gastric or Gastroesophageal Junction Cancer
— Estimated OS at 12 months of 76%
— ALX Oncology to Host Conference Call on July 6th at 8:30 a.m. ET
3 July, 2021 by The TZ Newswire Staff Comments Off on 2 Surefire Dividend Stocks That Should Win in the Next Stock Market Crash
2 Surefire Dividend Stocks That Should Win in the Next Stock Market Crash
Investing in dividend stocks can be a great way to build wealth over time. Companies that pay dividends usually have a history of profitable performance, and they have proven themselves through recessions and calamities like a pandemic.